Exelixis, Inc. (EXEL)
FlaggedUS listed · Healthcare · Biotechnology
This page tracks Exelixis, Inc. (EXEL) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews EXEL against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Oct 9, 2026Screen strength 4.4Several factors support the pre-screen's long bias: a 1.12 one-year Sharpe, a 52.5% one-year CAGR, price holding above the SMA-50 ($56.07) and SMA-200 ($49.40), and 52.7% TTM EPS growth. The risks to this setup are a MACD histogram that has turned slightly negative (-0.03) with no fresh crossover, a last-session volume of only 1.21x the 20-day average, and a price near its 52-week high ($61.14) after a strong run that leaves limited technical cushion. Earnings timing is not provided in the data and should be verified, since the stock's valuation is already being questioned in recent coverage.
EXEL AI Signal Track Record
Recent scanner signals for Exelixis, Inc.. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Oct 9, 2026 | Flagged | 4.4 | $60.45 |
| Oct 9, 2026 | Flagged | 4.4 | $60.21 |
| Oct 9, 2026 | Flagged | 4.1 | $59.72 |
| Oct 8, 2026 | Flagged | 4.8 | $60.02 |
| Oct 8, 2026 | Flagged | 4.8 | $59.87 |
| Oct 8, 2026 | Flagged | 4.8 | $59.82 |
EXEL — Frequently Asked Questions
Is Exelixis, Inc. (EXEL) a buy right now?
As of October 9, 2026, StockTracker AI's screen flags EXEL as Flagged, with a ±1.8% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is EXEL's RSI?
EXEL's 14-day RSI was 58.5 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for EXEL?
StockTracker AI generates a probability-weighted 30-day price forecast for EXEL — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze EXEL?
Each scan screens EXEL on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for EXEL — free.
Add EXEL to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for EXEL
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →